Asia-Pacific Pharma Market

Keeping up with the Pharmaceutical Industry in Asia

2019-07-08T13:19:44+00:00

Keeping up with pharmaceutical landscape around the world, especially in Asia, is essential in today’s market. Here are some of the biggest news stories emerging from Asian countries that are making big strides in drug development. China: Recently, China has been quickly advancing in the process of approving of new drugs. This is in accordance to the new drug registration procedure under the Chinese FDA(CFDA). This new process is helping China to beat other countries, including the US, in the process of bringing drugs to market. For example, China was able to grant Astrazeneca and FribroGen approval for the drug [...]

Keeping up with the Pharmaceutical Industry in Asia2019-07-08T13:19:44+00:00

China Reshaping the Clinical Trial Pipeline

2019-07-01T19:42:40+00:00

Finally, the data is in here at OZMOSI, and we can start tracking and reporting on the clinical development expected to come out of China.  Gone are the days of developing drugs only in the US and then watching them slowly make their way to the rest of the world. China’s current trial pipeline below illustrates a disease area focus that is on par with what we see and expect from the US, EU, and Japan.   And that’s only the beginning.  China is now taking a very active role in developing novel therapies directly, and not just for their own [...]

China Reshaping the Clinical Trial Pipeline2019-07-01T19:42:40+00:00